This concerted action thwarted the nuclear translocation of P65, thereby abrogating the activation of the nuclear factor kappa B (NFκB) signaling pathway and impeding ccRCC cell proliferation and metastasis. The gene discussed is NFKB1; the disease is nonpapillary renal cell carcinoma.